Magazine

Magazine

May 2018, Volume 4, Issue 6

This issue features a look at the hidden costs of importing lower-cost drugs, the optimal hemophilia treatment, the limits of genetic testing, and more.

Focus on Myeloid Malignancies (Volume 4, Issue 6.1)

This supplement features FDA updates, clinical trials, and the latest research in myeloid malignancies.

April 2018, Volume 4, Issue 5

This issue features a look at the U.S. health-care system’s transition from a paper-based system to electronic health records, an introduction to a series about oncology nurse practitioners, and more.

Focus on Lymphoma & Myeloma (Volume 4, Issue 4.1)

This supplement features a look at controversies in myeloma treatment, the future of immunotherapy for lymphoma, newly approved and investigational therapies, and more.

March 2018, Volume 4, Issue 4

This issue features a debate over whether CPX-351 can be used with other therapies in AML, a look at contract research organizations, and more.

February 2018, Volume 4, Issue 3

This issue features a conversation with National Cancer Institute Director Norman “Ned” Sharpless, MD, a look at the prevalence and controversial nature of academic-industry partnerships, and more.

January 2018 Annual Meeting Edition

This issue features highlights from the 2017 ASH Annual Meeting, including a look at the first anti-sickling agent for sickle cell disease, and more.

January 2018, Volume 4, Issue 1

This issue features a look at the misconceptions that challenge the viability of the blood-banking system, highlights from the 2017 ASH Annual Meeting, and more.

December 2017, Volume 3, Issue 14

This issue features physicians' insights on gun control, the use of cannabis for symptom relief, and more.

November 2017, Volume 3, Issue 13

This issue features a behind-the-scenes look at the ASH annual meeting, bringing newly approved gene therapies to patients, and more.
Advertisement

Current Issue

May 2018, Volume 4, Issue 6

This issue features a look at the hidden costs of importing lower-cost drugs, the optimal hemophilia treatment, the limits of genetic testing, and more.